Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.53
-$0.01-1.13%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.22M | 1.84M | 1.82M | 1.90M | 2.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.62M | 3.27M | 3.56M | 4.03M | 6.07M |
| Operating Income | -2.62M | -3.27M | -3.56M | -4.03M | -6.07M |
| Income Before Tax | -2.45M | -3.19M | -3.36M | -4.01M | -6.05M |
| Income Tax Expenses | 2.60K | 3.30K | 2.90K | 2.80K | 8.00K |
| Earnings from Continuing Operations | -2.45M | -3.20M | -3.37M | -4.01M | -6.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.45M | -3.20M | -3.37M | -4.01M | -6.05M |
| EBIT | -2.62M | -3.27M | -3.56M | -4.03M | -6.07M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.19 | -0.46 | -0.57 | -1.10 | -2.40 |
| Normalized Basic EPS | -0.12 | -0.28 | -0.35 | -0.69 | -1.50 |
| EPS Diluted | -0.19 | -0.46 | -0.57 | -1.10 | -2.40 |
| Normalized Diluted EPS | -0.12 | -0.28 | -0.35 | -0.69 | -1.50 |
| Average Basic Shares Outstanding | 13.21M | 7.02M | 5.94M | 3.63M | 2.52M |
| Average Diluted Shares Outstanding | 13.21M | 7.02M | 5.94M | 3.63M | 2.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |